Scope and a bird's eye view of on topic and On The Occasion It Is Used

Levothroid is a brand of levothyroxine sodium, a synthetic form of the thyroid hormone T4. It replaces or supplements the hormone when the body makes too little of its own.

Typical medical uses include:

  • Primary hypothyroidism where the thyroid gland underproduces hormone.
  • Central hypothyroidism arising from pituitary or hypothalamic dysfunction.
  • Management of certain benign goitres to reduce size or slow growth.
  • Part of thyroid cancer follow-up where suppression of TSH is indicated.

Important safety note: levothyroxine is not approved for weight loss or athletic enhancement. Misuse can cause serious cardiac and metabolic harm.

In Australia tablets are commonly available in strengths spanning roughly administer a dose of 25 micrograms to the dosage equals 200 micrograms. For advice on schedules and timing see How to Manage It: Dosing Information.

Go to top

Recommended Dosing Protocols and How to Administer It

Levothyroxine is usually prescribed as a long-term daily treatment. The dose is tailored by your prescriber to your age, weight, cardiac status, and laboratory results. Never change your dose or stop treatment without medical advice.

To promote consistent absorption and stable blood levels:

  • Take a single dose every day at about the same time. Many people take it first thing in the morning, 30 to 60 minutes before breakfast.
  • Some patients do well taking levothyroxine at bedtime if the stomach has been empty for several hours; discuss any timing change with your clinician plus then keep the routine steady.
  • Consume the pills with a glass of water. If you use a formulation intended to be dispersed, follow the leaflet or pharmacist instructions.
  • After starting or altering dose, TSH is usually measured about 6 to 8 weeks later to guide further adjustment.

If you are using supplements or medicines that affect absorption, consult Drug, Supplement and Food Interactions between parties for spacing recommendations.

Top of the page

Safety Facts and Automated monitoring

Certain health problems require closer supervision or altered dosing. Tell your prescriber if you have any of the following conditions:

  • Coronary artery disease, recent heart attack, irregular heartbeat or other serious heart conditions.
  • Known or suspected adrenal insufficiency that is untreated.
  • Active hyperthyroidism or uncontrolled thyrotoxicosis.
  • Bleeding tendency or if you are taking anticoagulants such as warfarin.
  • Type 2 diabetes, significant liver or kidney disease, osteoporosis, or malnutrition.

Pregnancy commonly increases the need for levothyroxine. Notify your prescriber if you are pregnant or planning pregnancy; more frequent TSH checks are typical. Breastfeeding is generally compatible with levothyroxine when used at prescribed doses, but follow clinical informed direction.

Move back to page top

Relative relative contramarkers and Practical Advice

Do not take levothyroxine if you have a known allergy to levothyroxine or any other ingredient in the tablet you were given.

  • Never use levothyroxine for dieting or sport enhancement; this is unsafe and not an approved indication.
  • If you have diabetes expect that thyroid replacement may change your glucose control and require adjustments to diabetes medicines.
  • If pregnancy is confirmed or suspected talk to your prescriber promptly about dose and testing.

When uncertain about an ingredient or formulation, ask the dispensing pharmacist or reassess the product leaflet.

Go scroll to the topmost level of the page

Likely after effects and warning signs

When used at the right dose levothyroxine is usually well tolerated. Negative reactions most often signal too much hormone replacement.

Seek swift medical care for fainting and loss of consciousness severe or life-threatening symptoms including:

  • Intense chest pain or chest pressure, pain spreading to jaw or arm.
  • Fast, pounding, or irregular heartbeats, fainting, or sudden collapse.
  • Sudden swelling of face, lips, throat or difficulty breathing.
  • Acute neurological changes such as severe cranial ache, slurred speech, or loss of coordination.

Milder signs of overreplacement can include nervousness, tremor, heat intolerance, excessive sweating, weight loss, cranial pains, muscle weakness, nausea, diarrhea, mood shifts and hair thinning. Report persistent or worrying symptoms so your clinician can review your dose and tests.

Proceed to the next top

Drug, Supplement and Food Exchanges and global teams rely on robust engagement and communications.

Various medicines, supplements and some foods reduce levothyroxine absorption or change its effect. Always list all medicines, vitamins and herbal products to any health professional you see.

  • Mineral-containing supplements and antacids with iron, calcium, aluminium or magnesium can bind levothyroxine; allow at least four hours between these products and your levothyroxine dose.
  • Fat absorption agents like orlistat, bile acid binders and some phosphate binders such as sevelamer may lower absorption.
  • Enzyme inducers (for example carbamazepine, phenytoin, rifampicin) and some antidepressants or antiarrhythmics can change thyroid hormone metabolism and increase dose needs.
  • Levothyroxine can increase the effect of oral anticoagulants; monitor INR when starting or changing thyroid therapy.
  • Food items such as soy products, high-fiber diets, coffee and grapefruit juice can interfere in some people; keep the timing with meals consistent.

For timing suggestions look back to The Dose Schedule and How to Handle It Best.

Up to the head

If you miss one dose

If you forget the dose, take it as soon as you remember unless it is nearly time for the next dose. Do not take two doses at once to make up for missed time. If the dose was misseds occur often, speak to your prescriber or pharmacist about reminder tools, weekly dosette packs or other adherence aids.

Go to top

Drug overdose - Emergency Steps

If you suspect an take an overdose contact emergency services right away. In Australia call the Poisons Information Centre on 13 11 26 for immediate, expert advice.

Major overdose death may cause severe agitation, high temperature with a weak or rapid pulse, fainting, or major neurological problems. Treatment in hospital is focused on stabilising the patient and treating symptoms.

Return to that point the highest point

On site inventory storage keeps products ready for sale. and Disposal Compliance Instructions

  • Store tablets at room temperature away from direct heat and sunlight.
  • Keep the medicine in its original packaging or blister to shield it from moisture; bathroom storage capacity determines how much you can keep. is not recommended.
  • Do not freeze. Keep this out of the reach and out of the line of sight of children and pets. Dispose of expired or unwanted medicine via pharmacy return programs or local disposal instruction.

Ask your pharmacist for safe disposal options when you no longer need the medication.

Revert to the page top

Different methods of treatment and Short Comparison

Other thyroid hormone options that may be considered in Australia include:

  • Different levothyroxine brands such as Oroxine or Eutroxsig. These contain the same active ingredient; tablet appearance and excipients may differ. If a brand is changed, repeat TSH testing in 6 to 8 weeks.
  • Liothyronine (T3) preparations, which act faster and are used in specific circumstances; these are typically more expensive and used less often for routine replacement.
  • Combined T4/T3 therapy is sometimes trialed for persistent symptoms despite normal tests; this is managed by a specialist and is not standard for most patients.
  • Natural desiccated thyroid and bespoke compounded formulas are not commonly registered in Australia and often need special access approvals; availability, regulation and cost differ from standard products.

In general most people achieve good control with levothyroxine (T4) alone. Any product change should be followed by clinical review and TSH testing after about 6 to 8 weeks.

See price and subsidy notes for a rough comparison in Australian american dollars.

Go back to the top tier of the page

Estimated Costs and Subsidy Notes (AUD)

Many levothyroxine brands are subsidised under the Pharmaceutical Benefits Scheme (PBS), which lowers the cost for eligible Australians. Below are indicative figures and can change.

  • Typical PBS general patient co-payment: approximately AUD 30 to AUD 33 per subsidised script.
  • Concession card holders: reduced co-payment, often around AUD 6 to AUD 9 per script.
  • Small private packs or non-subsidised purchases can vary widely; expect roughly AUD 8 to AUD 30 or more depending on brand and pack size plus the pharmacy mark-up.

Other products such as liothyronine (T3) are often pricier and may not receive the same subsidy. Non-registered or compounded preparations can be substantially more expensive and are rarely PBS-subsidised.

Final out-of-pocket cost depends on brand, pack size, dispensing fee, and whether you qualify for Safety Net or concession pricing approach. Confirm current pricing approach with your pharmacist or via the PBS website before purchase.

Return to the earlier section the very top

Frequently Asked Questions

In how short a time will I feel better? Some patients notice symptom improvements within 4 to 8 weeks, but it can take longer to reach a stable biochemical status and dose.

Can I accept a different brand from my pharmacy? Changing brands is usually acceptable but try to remain on one brand when possible. Arrange TSH testing about 6 to 8 weeks after switching to confirm stability.

Is taking levothyroxine at night acceptable? Bedtime dosing works for many people if the stomach is empty for several hours beforehand; consistency is the key. Discuss any change in cooperation with your prescriber.

Where do I get personalised advice? Your treating doctor with the addition of the community pharmacist can give guidance that accounts for your medical history, current medicines and personal circumstances. For regulatory or import questions consult the TGA.

Return to the original page page top

Additional aspects about Levothroid